We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

230 hedge funds and large institutions have $1.73B invested in Dr. Reddy's Laboratories in 2024 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 92 increasing their positions, 73 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more call options, than puts

Call options by funds: $1.91M | Put options by funds: $733K

45% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 20

26% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 73

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

3% more funds holding

Funds holding: 223 → 230 (+7)

2% more capital invested

Capital invested by funds: $1.7B → $1.73B (+$37.4M)

2.23% less ownership

Funds ownership: 73.05% → 70.81% (-2.2%)

Holders
230
Holders Change
+7
Holders Change %
+3.14%
% of All Funds
3.31%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
29
Increased
92
Reduced
73
Closed
20
Calls
$1.91M
Puts
$733K
Net Calls
+$1.18M
Net Calls Change
-$648K

Top Buyers

1
Bank of America
Bank of America
North Carolina
+$24M
2
Robeco Institutional Asset Management
Robeco Institutional Asset Management
Netherlands
+$18.2M
3
JP Morgan Chase
JP Morgan Chase
New York
+$16.3M
4
Millennium Management
Millennium Management
New York
+$13.6M
5
AIM
Aikya Investment Management
United Kingdom
+$10.5M

Top Sellers

1
BlackRock
BlackRock
New York
-$60.1M
2
Morgan Stanley
Morgan Stanley
New York
-$55.5M
3
Goldman Sachs
Goldman Sachs
New York
-$20.3M
4
Lazard Asset Management
Lazard Asset Management
New York
-$13.1M
5
Citadel Advisors
Citadel Advisors
Florida
-$7.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
PS
226
Principal Securities
Iowa
$1.25K -$1.02K -70 -45%
CA
227
Continuum Advisory
Idaho
$764 +$803 +55 New
AF
228
Advisornet Financial
Minnesota
$587 – – –
Credit Agricole
229
Credit Agricole
France
$425 -$8.47K -580 -95%
HNB
230
Huntington National Bank
Ohio
$73 -$6.86K -470 -99%
DCM
231
Driehaus Capital Management
Illinois
– -$4.37M -314,100 Closed
GH
232
GAM Holding
Switzerland
– -$3.2M -230,000 Closed
Natixis Advisors
233
Natixis Advisors
Massachusetts
– -$805K -57,875 Closed
GCM
234
Graham Capital Management
Connecticut
– -$740K -53,195 Closed
D.E. Shaw & Co
235
D.E. Shaw & Co
New York
– -$707K -50,790 Closed
PAM
236
Pinpoint Asset Management
Hong Kong
– -$331K -23,750 Closed
MM
237
MQS Management
New York
– -$225K -16,160 Closed
TI
238
Trexquant Investment
Connecticut
– -$219K -15,760 Closed
GT
239
Glenmede Trust
Pennsylvania
– -$212K -15,200 Closed
Point72 Asset Management
240
Point72 Asset Management
Connecticut
– -$167K -12,000 Closed
PHK
241
Point72 Hong Kong
Hong Kong
– -$74.2K -5,335 Closed
PVH
242
Psagot Value Holdings
Israel
– -$28K -2,000 Closed
GWS
243
Glassman Wealth Services
Virginia
– -$18.2K -1,310 Closed
GKIM
244
GW&K Investment Management
Massachusetts
– -$15K -1,075 Closed
PB
245
Pinnacle Bancorp
Nebraska
– -$9.04K -650 Closed
TPCW
246
TD Private Client Wealth
New York
– -$7.93K -570 Closed
GI
247
Gradient Investments
Minnesota
– -$3.97K -285 Closed
ASN
248
Advisory Services Network
Georgia
– -$2.23K -160 Closed
PTC
249
Private Trust Company
Ohio
– -$835 -60 Closed
FHA
250
First Horizon Advisors
Tennessee
– -$347 -25 Closed
6 7 8 9
10

RDY Hedge Fund Activity: Q1 2024 in Review

230 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2024, worth a combined $1.73B — up 2.2% from $1.7B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new RDY positions and 20 closed out — a net gain of 9 holders — while 92 added to existing stakes and 73 trimmed.

The largest buyer was Bank of America, adding an estimated $24M. The largest seller was BlackRock, cutting an estimated $60.1M.

  • 230 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2024, up from 223 in Q4 2023.
  • Funds reported $1.73B of Dr. Reddy's Laboratories stock for Q1 2024, up 2.2% quarter-over-quarter.
  • 29 funds opened new Dr. Reddy's Laboratories positions in Q1 2024 and 20 closed out, a net change of +9 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q1 2024 was Bank of America, an estimated $24M added.
  • The largest Dr. Reddy's Laboratories seller in Q1 2024 was BlackRock, an estimated $60.1M sold.

Based on aggregated 13F filings for Q1 2024.